Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients.

We found that, when compared to baseline levels, ACE2 activities were further elevated during the hospital treatment of critically ill patients (P < 0.0001), in contrast to severely ill study participants in whom alterations did not reach statistical significance during hospital stay (P = 0.0579) ( Figure 2 A).

also in 111,027 other papers